VigeneTech, Inc, in collaboration with BioLegend, Inc., today announced the release of LEGENDplex(TM) Data Analysis Software, an OEM software solution for analysis of multiplex data from flow cytometers. BioLegend develops and offers varieties of bead-based multi-analyte immunoassay products for use with flow cytometers. With the support of VigeneTech’s data analysis software, FCS data files can be automatically and accurately analyzed and easily reported.
Truven Health Analytics recently announced it has successfully linked electronic medical records (EMR) and administrative claims data with significant volume to power oncology-focused outcomes research studies. This de-identified data set, the newest addition to the MarketScan® research databases, provides a unique ability for researchers to better understand total healthcare costs, co-morbidities, adverse events, and outcomes for cancer patients by treatment phase, biomarker status, and tumor stage.
Restore Health, a leading personalized medicine company that provides specialty and compounded pharmaceuticals, announced that it is now offering pharmacogenetic testing that provides drug sensitivity information unique to each individual based upon their particular genetic makeup. Comprehensive medication management is now possible by understanding the interaction between a patient’s genetics and their entire drug regimen.
Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating
Two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), recently announced what is likely the largest collaboration of its kind to accelerate discoveries in cancer research.
MedPage Today and CollabRx Introduce CancerRx, A New Decision Support Mobile Application for Oncology
MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), and CollabRx, Inc. (NASDAQ: CLRX) recently announced the introduction of a new physician resource, CancerRx,™ an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options.